Swedish Orphan Biovitrum AB: Late-breaking efanesoctocog alfa data presented at ISTH demonstrates highly effective bleed protection in children with severe haemophilia A with once-weekly dosing ...Middle East

XTEND-Kids data confirms the efficacy and safety profile of efanesoctocog alfa with 50 IU/kg dosing in previously treated children as already shown in adults and adolescents. Factor VIII inhibitor development was not detected during the study. Once-weekly efanesoctocog alfa was shown to...

Hence then, the article about swedish orphan biovitrum ab late breaking efanesoctocog alfa data presented at isth demonstrates highly effective bleed protection in children with severe haemophilia a with once weekly dosing was published today ( Sunday 25/06/2023 - 06:25 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Swedish Orphan Biovitrum AB: Late-breaking efanesoctocog alfa data presented at ISTH demonstrates highly effective bleed protection in children with severe haemophilia A with once-weekly dosing )

Also on site :

• Thousands rally in Serbia as students continue fight against corruption
• Today’s NYT ‘Strands’ Hints, Spangram and Answers for Sunday, January 18, 2026
• Trump selling seats on Gaza ‘Board of Peace’ for $1bn